TheProfitWatch

ATAI - ATAI Life Sciences N.V. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.61 0.19 (5.26%) -0.01 (-0.13%) -0.01 (-0.26%) 0.01 (0.4%) 0.1 (2.77%) 0.15 (4.11%) -0.05 (-1.31%) 0.0 (0.03%)

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.14
Diluted EPS:
-0.14
Basic P/E:
-27.1429
Diluted P/E:
-27.1429
RSI(14) 1m:
58.84
VWAP:
3.8
RVol:

Events

Period Kind Movement Occurred At

Related News